Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Management Inc. Altiva currently holds 8,011,733 shares of PROGENICS PHARMACEUTICALS INC (PGNX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Management Inc. Altiva has been a net buyer of PGNX stock. They have purchased $359.4K and sold $0 worth of shares.
Management Inc. Altiva's most recent insider trade was on Sep 9, 2019, when they purchased 72,023 shares at $4.99 per share.
Management Inc. Altiva serves as Executive at PROGENICS PHARMACEUTICALS INC (PGNX). They have executed 1 insider transactions totaling $359.4K over their tenure at the company.
Management Inc. Altiva holds the position of Executive at PROGENICS PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Management Inc. Altiva has shown a buying trading pattern, with $359.4K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Management Inc. Altiva was on Sep 9, 2019, when they purchased $359.4K worth of PGNX shares. This transaction involved 72,023 shares at $4.99 per share.
Management Inc. Altiva currently owns 8,011,733 shares of PROGENICS PHARMACEUTICALS INC (PGNX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Management Inc. Altiva's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Management Inc. Altiva has 1 Form 4 filings on record as an insider at PROGENICS PHARMACEUTICALS INC.
Set alerts for Management Inc. Altiva and 40,000+ other insiders.